Gene · 1291
Papers2,357
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,357
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning and 4D-LFQ quantitative proteomic analysis explore the molecular mechanism of kidney stone formation. | Heliyon | 2024 | 39114033 | PubTator, text mining | PubMed |
| Phenotype-genotype spectrum of a cohort of congenital muscular dystrophies: a single-centre experience from India. | Neurogenetics | 2024 | 39103709 | PubTator, text mining | PubMed |
| Weighted Gene Co-expression Network Analysis (WGCNA) of Wnt Signaling Related to Periodontal Ligament Formation: A Bioinformatics-Based Analysis. | Cureus | 2024 | 39092323 | PubTator, text mining | PubMed |
| Anti-photoaging effect and the mechanism of Coreopsis tinctoria okanin against UVB-induced skin damage in mice. | Int Immunopharmacol | 2024 | 39024749 | PubTator, text mining | PubMed |
| The lung extracellular matrix protein landscape in severe early-onset and moderate chronic obstructive pulmonary disease. | Am J Physiol Lung Cell Mol Physiol | 2024 | 38915286 | PubTator, text mining | PubMed |
| Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma. | CNS Neurosci Ther | 2024 | 38887185 | PubTator, text mining | PubMed |
| Proteomic profile of tissue-derived extracellular vesicles from benign odontogenic lesions. | J Stomatol Oral Maxillofac Surg | 2024 | 38795909 | PubTator, text mining | PubMed |
| Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis. | Neurogenetics | 2024 | 38775886 | PubTator, text mining | PubMed |
| Expert Panel Curation of 31 Genes in Relation to Limb Girdle Muscular Dystrophy. | bioRxiv | 2024 | 38765987 | PubTator, text mining | PubMed |
| Collagen and Alginate Hydrogels Support Chondrocytes Redifferentiation In Vitro without Supplementation of Exogenous Growth Factors. | ACS Omega | 2024 | 38764657 | PubTator, text mining | PubMed |
| A Mild But Typical Presentation of Bethlem Myopathy With a Novel In-Frame Deletion in COL6A1: Almost Overlooked. | Neurology | 2024 | 38754040 | PubTator, text mining | PubMed |
Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancer. | Investig Clin Urol | 2024 | 38714517 | PubTator, text mining | PubMed |
| Exome sequencing in extreme altitude mountaineers identifies pathogenic variants in RTEL1 and COL6A1 previously associated with respiratory failure. | Physiol Rep | 2024 | 38653581 | PubTator, text mining | PubMed |
| Identification of hub genes and key pathways in spinal cord injury via bioinformatics analysis. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38650155 | PubTator, text mining | PubMed |
| Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation. | Eur J Med Res | 2024 | 38643140 | PubTator, text mining | PubMed |
| Gadolinium retention effect on macrophages - a potential cause of MRI contrast agent Dotarem toxicity. | Cell Tissue Res | 2024 | 38625373 | PubTator, text mining | PubMed |
| Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy. | Mol Ther Nucleic Acids | 2024 | 38617974 | PubTator, text mining | PubMed |
| [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 38595234 | PubTator, text mining | PubMed |
| A humanized knock-in Col6a1 mouse recapitulates a deep-intronic splice-activating variant. | bioRxiv | 2024 | 38585878 | PubTator, text mining | PubMed |
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy. | medRxiv | 2024 | 38585825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1291/papers?page=8